[November 26, 2014]

Visualant to Present at 7th Annual LD MICRO Conference on December 2, 2014 and Benchmark's Micro Cap Discovery Conference December 11, 2014

Visualant, Inc. (OTCQB: VSUL), a leading provider of disruptive light-based technologies through its ChormaID™ technology, announced today that the Company will participate in two upcoming investor conferences. The conference details are as follows:

• Visualant President and CEO Ron Erickson is scheduled to present at the LD Micro Conference on Tuesday, December 2nd at 7:30 a.m. PST in Track 3, with one-on-one meetings held throughout the day. He will discuss the company's new strategic partnership with Intellectual Ventures, the global leader in the business of invention, to advance the commercialization of Visualant's patented ChormaID™ technology through product applications and IP development. Visualant has approximately 30 patents filed to date and 7 have been issued.
  
  Management's presentation will be webcast live via http://wsw.com/webcast/ldmicro5/VSUL, and available for replay following the conference in the investors section of Visualant's website at www.visualant.net. For additional information about the LD MICRO Confrence, please visit www.ldmicro.com or email [email protected] for 1 on 1 meeting slots.
• Benchmark's Micro Cap Discovery Conference to be held on Thursday, December 11, 2014 at the Palmer House Hilton in Chicago, Illinois. Mr. Erickson will participate in one-on-one investor meetings from 8:00 am - 3:30 pm CST.
  
  
  
  
  
  For additional information about the Benchmark Micro Cap Discovery Conference, contact your institutional salesperson or visit http://www.benchmarkcompany.com/conference.php

About Visualant, Inc.

Visualant™ is a public company whose shares trade under the stock symbol "VSUL." The Visualant Spectral Pattern Matching™ (SPM) technology directs structured light onto a substance or material, through a liquid or gas, or off a surface, to capture a unique ChormaID™. A ChormaID can be used to identify, detect, or diagnosis markers invisible to the human eye. ChormaID scanner modules can be integrated into a variety of mobile or fixed-mount form factors. The patented, award-winning technology is disruptive, making it possible to effectively conduct analyses in the field that could only previously be performed by large and expensive lab-based tests. For more information on Visualant, visit the company's new website at www.visualant.net.

About LD Micro

LD Micro is an investment newsletter firm that focuses on finding undervalued companies in the micro-cap space. Since 2002, the firm has published reports on select companies throughout the year. The firm also hosts the LD Micro Invitational. It is a non-registered investment advisor. For more information, please contact 408-457-1042 or visit www.ldmicro.com.

About The Benchmark Company

Headquartered in New York with 11 offices coast to coast, The Benchmark Company, LLC is an institutional brokerage firm that provides Research, Sales, Trading and Investment Banking services to public companies and their investors.

[ Back To TMCnet.com's Homepage ]